143 related articles for article (PubMed ID: 3028132)
1. Restoration of impaired natural killer cell activity of B-chronic lymphocytic leukemia patients by recombinant interleukin-2.
Kay NE; Zarling J
Am J Hematol; 1987 Feb; 24(2):161-7. PubMed ID: 3028132
[TBL] [Abstract][Full Text] [Related]
2. Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells.
Kay NE; Zarling JM
Blood; 1984 Feb; 63(2):305-9. PubMed ID: 6607080
[TBL] [Abstract][Full Text] [Related]
3. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.
Foa R; Lauria F; Lusso P; Giubellino MC; Fierro MT; Ferrando ML; Raspadori D; Matera L
Br J Haematol; 1984 Nov; 58(3):509-16. PubMed ID: 6333890
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
Chang WC; Hsiao MH; Pattengale PK
Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
[TBL] [Abstract][Full Text] [Related]
5. Feline cytotoxic large granular lymphocytes induced by recombinant human IL-2.
Tompkins MB; Pang VF; Michaely PA; Feinmehl RI; Basgall EJ; Baszler TV; Zachary JF; Tompkins WA
J Immunol; 1989 Jul; 143(2):749-54. PubMed ID: 2544649
[TBL] [Abstract][Full Text] [Related]
6. Lymphokine induction of NK-like cytotoxicity in T cells from B-CLL.
Alvarez de Mon M; Casas J; Laguna R; Toribio ML; de Landázuri MO; Durántez A
Blood; 1986 Jan; 67(1):228-32. PubMed ID: 3079643
[TBL] [Abstract][Full Text] [Related]
7. Lytic activity of IL-2 and IL-12 stimulated NK cells against HOS osteosarcoma cell line.
Mariani E; Tarozzi A; Meneghetti A; Tadolini M; Facchini A
Boll Soc Ital Biol Sper; 1996; 72(1-2):21-7. PubMed ID: 8868111
[TBL] [Abstract][Full Text] [Related]
8. Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells.
Pattengale PK; Gidlund M; Nilsson K; Sundström C; Sällström J; Simonsson B; Wigzell H
Int J Cancer; 1982 Jan; 29(1):1-7. PubMed ID: 6174459
[TBL] [Abstract][Full Text] [Related]
9. In vitro enhancement of natural killer cell activity against herpesvirus-infected targets in patients with acute lymphocytic leukemia.
McKolanis JR; Ragab AH; Schmid DS
Arch Virol; 1991; 117(1-2):17-28. PubMed ID: 1848749
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
Ostensen ME; Thiele DL; Lipsky PE
J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. III. Defective interleukin-2 production by T-helper and natural killer cells.
Chang WC; Fujimiya Y; Casteel N; Pattengale P
Int J Cancer; 1989 Apr; 43(4):591-7. PubMed ID: 2522912
[TBL] [Abstract][Full Text] [Related]
12. Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia.
Allen JI; Syropoulos HJ; Grant B; Eagon JC; Kay NE
J Lab Clin Med; 1987 Apr; 109(4):396-401. PubMed ID: 3493314
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia.
Ziegler HW; Kay NE; Zarling JM
Int J Cancer; 1981 Mar; 27(3):321-7. PubMed ID: 6169660
[TBL] [Abstract][Full Text] [Related]
14. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
Ramsey KM; Djeu JY; Rook AH
Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
[TBL] [Abstract][Full Text] [Related]
16. Characterization of antileukemia cells' cytotoxic effector function. Implications for monitoring natural killer responses following allogeneic bone marrow transplantation.
Delmon L; Ythier A; Moingeon P; Nowill A; Bayle C; Pico JL; Hayat M; Ritz J; Hercend T
Transplantation; 1986 Sep; 42(3):252-6. PubMed ID: 3529526
[TBL] [Abstract][Full Text] [Related]
17. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
Lotzová E; Savary CA; Herberman RB
J Immunol; 1987 Apr; 138(8):2718-27. PubMed ID: 3494084
[TBL] [Abstract][Full Text] [Related]
18. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism.
Abrams SI; Brahmi Z
Cell Immunol; 1986 Sep; 101(2):558-70. PubMed ID: 3489541
[TBL] [Abstract][Full Text] [Related]
19. Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells.
Robinson BW; Morstyn G
Cell Immunol; 1987 May; 106(2):215-22. PubMed ID: 3494538
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
Kaufmann Y; Levanon M; Davidsohn J; Ramot B
J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
